Adrenergic Effect on Cytokine Release After Ex Vivo Healthy Volunteers' Whole Blood LPS Stimulation

Inflammation. 2016 Jun;39(3):1069-75. doi: 10.1007/s10753-016-0338-y.

Abstract

Catecholamines are molecules with immunomodulatory properties in health and disease. Several studies showed the effect of catecholamines when administered to restore hemodynamic stability in septic patients. This study investigates the effect of norepinephrine and dobutamine on whole blood cytokine release after ex vivo lipopolysaccharide (LPS) stimulation. Whole blood collected from healthy individuals was stimulated with LPS, in the presence of norepinephrine or dobutamine at different concentrations, with or without metoprolol, a β1 receptor antagonist. Cytokine measurement was performed in isolated cell culture supernatants with ELISA. Results are expressed as mean ± SEM and compared with Mann-Whitney rank-sum test. Both norepinephrine and dobutamine significantly reduced TNF-α and IL-6 production after ex vivo LPS stimulation of whole blood in a dose-dependent manner, and this effect was partially reversed by the presence of metoprolol. Norepinephrine and dobutamine reduce the LPS-induced production of pro-inflammatory cytokines, thus possibly contributing to altered balance between the inflammatory and anti-inflammatory responses, which are vital for a successful host response to severe disease, shock, and sepsis.

Keywords: dobutamine; inflammation; norepinephrine; sepsis.

MeSH terms

  • Adrenergic Agents / pharmacology*
  • Blood / drug effects*
  • Cytokines / drug effects
  • Cytokines / metabolism*
  • Dobutamine / pharmacology
  • Dose-Response Relationship, Drug
  • Healthy Volunteers
  • Humans
  • Interleukin-6 / biosynthesis
  • Lipopolysaccharides / pharmacology
  • Norepinephrine / pharmacology
  • Sepsis / blood*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Adrenergic Agents
  • Cytokines
  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Dobutamine
  • Norepinephrine